Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Conductive polymer and a solid electrolytic capacitor using the same as a solid electrolyte
Communication apparatus and communication system
System and method for associating financial transaction data with user's project data
Extensible framework for client-based active network measurement
Process for producing a carbon-comprising support
Technology for managing traffic via dual homed connections in communication networks
Image forming apparatus, image forming method, and computer readable medium for identifying target-recording element using detection pattern
  Randomly Featured Patents
Engine controlling apparatus for an automotive engine
Road Trailer
Portable traffic warning sign
Rope clamping arrangements for sailboats or other applications
Heat sink assembly including a heat pipe and a duct
Method for raising and lowering the feed and delivery tables of a printing press
Tray locking device of optical disc drive with anti-shock mechanism
Film processor
Cellulosic, modified lignin and cationic polymer composition and process for making improved paper or paperboard
Multi-layer covering